News this week that sexually transmitted disease (STD) reported cases in the U.S. reached all-time highs for the sixth straight year shows why STD clinic access to 340B drug discounts is vital, state and local STD program directors say.
New data published April 13 by U.S. Centers for Disease Control and Prevention found more than 2.5 million combined cases of chlamydia, gonorrhea, and syphilis reported in the U.S. in 2019, a nearly 30% increase in these STDs from 2015. “Preliminary 2020 data suggest that many of these concerning trends continued in 2020, when much of the country experienced major disruptions to STD testing and treatment services due to the COVID-19 pandemic,” CDC said in a news release.
News this week that sexually transmitted disease (STD) reported cases in the U.S. reached all-time highs for the sixth straight year shows why STD clinic access to 340B drug discounts is vital, state and local STD program directors say.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
